{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:05:08Z","timestamp":1781525108993,"version":"3.54.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03564-9","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T03:36:43Z","timestamp":1747453003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Molecular pathway and mechanism responsible for the progress of thyroid-associated orbitopathy"],"prefix":"10.1007","volume":"45","author":[{"given":"Jyotsana","family":"Dwivedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhi","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranay","family":"Wal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Wal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Gasmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"key":"3564_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7010196","author":"N Turck","year":"2018","unstructured":"Turck N, Eperon S, De Los Angeles Gracia M, Ob\u00e9ric A, Ham\u00e9dani M (2018) Thyroid-associated orbitopathy and biomarkers: where we are and what we can hope for the future. Dis Markers. https:\/\/doi.org\/10.1155\/2018\/7010196","journal-title":"Dis Markers"},{"issue":"4","key":"3564_CR2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1590\/s1679-45082016rc3744","volume":"14","author":"MLR Monteiro","year":"2016","unstructured":"Monteiro MLR, Gon\u00e7alves ACP, Bezerra AMPS (2016) Isolated primary amyloidosis of the inferior rectus muscle mimicking Graves\u2019 orbitopathy. Einstein 14(4):553\u2013556","journal-title":"Einstein"},{"key":"3564_CR3","volume-title":"Graves\u2019 orbitopathy. A multidisciplinary approach","author":"J Orgiazzi","year":"2007","unstructured":"Orgiazzi J (2007) Graves\u2019 orbitopathy. A multidisciplinary approach. Karger Publishers, Basel"},{"issue":"12","key":"3564_CR4","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1167\/iovs.06-0596","volume":"47","author":"L Zhang","year":"2006","unstructured":"Zhang L, Baker G, Janus D, Paddon CA, Fuhrer D, Ludgate M (2006) Biological effects of thyrotropin receptor activation on human orbital preadipocytes. Invest Ophthalmol Vis Sci 47(12):5197\u20135203","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"3564_CR5","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","volume":"181","author":"S Tsui","year":"2008","unstructured":"Tsui S, Naik V, Hoa N, Hwang CJ, Afifiyan NF, Sinha Hikim A, Gianoukakis AG, Douglas RS, Smith TJ (2008) Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves\u2019 disease. J Immunol 181(6):4397\u20134405","journal-title":"J Immunol"},{"issue":"19","key":"3564_CR6","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.1073\/pnas.1202064109","volume":"109","author":"R Fernando","year":"2012","unstructured":"Fernando R, Atkins S, Raychaudhuri N, Lu Y, Li B, Douglas RS, Smith TJ (2012) Human fibrocytes coexpress thyroglobulin and thyrotropin receptor. Proc Natl Acad Sci 109(19):7427\u20137432","journal-title":"Proc Natl Acad Sci"},{"key":"3564_CR7","unstructured":"Perros, P. & Kendall-Taylor, P. Demonstration of thyrotropin binding sites in orbital connective tissue: possible role in the pathogenesis of thyroid-associated ophthalmopathy."},{"key":"3564_CR8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/bjo.2004.050807","volume":"89","author":"A Boschi","year":"2005","unstructured":"Boschi A et al (2005) Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy. Br J Ophthalmol 89:724\u2013729","journal-title":"Br J Ophthalmol"},{"key":"3564_CR9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1530\/eje.1.01900","volume":"152","author":"P Agretti","year":"2005","unstructured":"Agretti P et al (2005) evidence for protein and mrNA TsHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation. Eur J Endocrinol 152:777\u2013784","journal-title":"Eur J Endocrinol"},{"key":"3564_CR10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2249.2005.02824.x","volume":"141","author":"TJ Smith","year":"2005","unstructured":"Smith TJ (2005) Insights into the role of fibroblasts in human autoimmune diseases. Clin Exp Immunol 141:388\u2013397","journal-title":"Clin Exp Immunol"},{"key":"3564_CR11","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","volume":"24","author":"BS Prabhakar","year":"2003","unstructured":"Prabhakar BS, Bahn RS, Smith TJ (2003) Current perspective on the pathogenesis of Graves\u2019 disease and ophthalmopathy. Endocr Rev 24:802\u2013835","journal-title":"Endocr Rev"},{"key":"3564_CR12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/1521-4141(200202)32:2<477::AID-IMMU477>3.0.CO;2-U","volume":"32","author":"L Koumas","year":"2002","unstructured":"Koumas L, Smith TJ, Phipps RP (2002) Fibroblast subsets in the human orbit: Thy-1+ and Thy-1-subpopulations exhibit distinct phenotypes. Eur J Immunol 32:477\u2013485","journal-title":"Eur J Immunol"},{"key":"3564_CR13","doi-asserted-by":"crossref","first-page":"E1236","DOI":"10.1210\/jc.2013-4271","volume":"99","author":"R Fernando","year":"2014","unstructured":"Fernando R, Lu Y, Atkins SJ et al (2014) Expression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter, and thyroperoxidase by fibrocytes depends on AIRE. J Clin Endocrinol Metab 99:E1236\u2013E1244","journal-title":"J Clin Endocrinol Metab"},{"key":"3564_CR14","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1167\/iovs.14-14002","volume":"55","author":"Y Wang","year":"2014","unstructured":"Wang Y, Smith TJ (2014) Current concepts in the molecular pathogenesis of thyroidassociated ophthalmopathy. Investig Ophthalmol Vis Sci 55:1735\u20131748","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3564_CR15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/jc.2009-1614","volume":"95","author":"RS Douglas","year":"2010","unstructured":"Douglas RS, Afifiyan NF, Hwang CJ et al (2010) Increased generation of fibrocytes in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 95:430\u2013438","journal-title":"J Clin Endocrinol Metab"},{"key":"3564_CR16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1371\/journal.pone.0007475","volume":"4","author":"D Pilling","year":"2009","unstructured":"Pilling D, Fan T, Huang D et al (2009) Identification of markers that distinguish monocytederived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS ONE 4:10","journal-title":"PLoS ONE"},{"key":"3564_CR17","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1046\/j.1523-1747.2002.19617.x","volume":"119","author":"A Slominski","year":"2002","unstructured":"Slominski A, Wortsman J, Kohn L et al (2002) Expression of hypothalamic-pituitarythyroid axis related genes in the human skin. J Invest Dermatol 119:1449\u20131455","journal-title":"J Invest Dermatol"},{"key":"3564_CR18","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/mend.12.10.0175","volume":"12","author":"H Shimura","year":"1998","unstructured":"Shimura H, Miyazaki A, Haraguchi K et al (1998) Analysis of differentiation-induced expression mechanisms of thyrotropin receptor gene in adipocytes. Mol Endocrinol 12:1473\u20131486","journal-title":"Mol Endocrinol"},{"key":"3564_CR19","doi-asserted-by":"crossref","first-page":"E740","DOI":"10.1210\/jc.2011-2514","volume":"97","author":"EF Gillespie","year":"2012","unstructured":"Gillespie EF, Papageorgiou KI, Fernando R et al (2012) Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production. J Clin Endocrinol Metab 97:E740\u2013E746","journal-title":"J Clin Endocrinol Metab"},{"key":"3564_CR20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-0029-1211178","volume":"100","author":"A Heufelder","year":"1992","unstructured":"Heufelder A, Bahn R (1992) Evidence for the presence of a functional TSH-receptor in retroocular fibroblasts from patients with Graves\u2019 ophthalmopathy. Exp Clin Endocrinol 100:62\u201367","journal-title":"Exp Clin Endocrinol"},{"key":"3564_CR21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1089\/thy.2007.0407","volume":"18","author":"GM Lehmann","year":"2008","unstructured":"Lehmann GM, Feldon SE, Smith TJ, Phipps RP (2008) Immune mechanisms in thyroid eye disease. Thyroid 18:959\u2013965","journal-title":"Thyroid"},{"key":"3564_CR22","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1167\/iovs.08-2328","volume":"50","author":"CJ Hwang","year":"2009","unstructured":"Hwang CJ, Afifiyan N, Sand D, Naik V, Said J, Pollock SJ et al (2009) Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest Ophthalmol Vis Sci 50:2262\u20132268","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3564_CR23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.exer.2015.02.007","volume":"142","author":"WA Dik","year":"2016","unstructured":"Dik WA, Virakul S, van Steensel L (2016) Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves\u2019 ophthalmopathy. Exp Eye Res 142:83\u201391","journal-title":"Exp Eye Res"},{"issue":"1","key":"3564_CR24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s43094-022-00425-5","volume":"8","author":"P Wal","year":"2022","unstructured":"Wal P, Dwivedi J, Wal A, Vig H, Singh Y (2022) Detailed insight into the pathophysiology and the behavioral complications associated with the Parkinson\u2019s disease and its medications. Future J Pharma Sci 8(1):33","journal-title":"Future J Pharma Sci"},{"key":"3564_CR25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2265.2007.02854.x","volume":"67","author":"T Bednarczuk","year":"2007","unstructured":"Bednarczuk T et al (2007) susceptibility genes in Graves\u2019 ophthalmopathy: searching for a needle in a haystack? Clin Endocrinol (Oxf) 67:3\u201319","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"14","key":"3564_CR26","doi-asserted-by":"crossref","first-page":"1292519","DOI":"10.3389\/fendo.2023.1292519","volume":"4","author":"H Zhang","year":"2023","unstructured":"Zhang H, Fan J, Qu J, Han Q, Zhou H, Song X (2023) Predictive markers for anti-inflammatory treatment response in thyroid eye disease. Front Endocrinol 4(14):1292519","journal-title":"Front Endocrinol"},{"key":"3564_CR27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2265.1996.8220832.x","volume":"45","author":"J Pfeilschifter","year":"1996","unstructured":"Pfeilschifter J, Ziegler R (1996) smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. Clin Endocrinol (Oxf) 45:477\u2013481","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3564_CR28","first-page":"3249","volume":"41","author":"M Crisp","year":"2000","unstructured":"Crisp M, Starkey KJ, Lane C et al (2000) Adipogenesis in thyroid eye disease. Invest Ophthalmol Vis Sci 41:3249\u20133255","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3564_CR29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/eye.1998.57","volume":"12","author":"A Pappa","year":"1998","unstructured":"Pappa A, Jackson P, Stone J et al (1998) An ultrastructural and systemic analysis of glycosaminoglycans in thyroid-associated ophthalmopathy. Eye 12:237\u2013244","journal-title":"Eye"},{"key":"3564_CR30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2249.1998.00613.x","volume":"112","author":"G Forster","year":"1998","unstructured":"Forster G, Otto E, Hansen C et al (1998) Analysis of orbital T cells in thyroid-associated ophthalmopathy. Clin Exp Immunol 112:427\u2013434","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"3564_CR31","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/cen.14316","volume":"94","author":"B Chen","year":"2021","unstructured":"Chen B et al (2021) Increased IL-17 levels in Graves\u2019 orbitopathy patients. Clin Endocrinol (Oxf) 94(5):721\u2013729","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"3564_CR32","first-page":"102","volume":"45","author":"B Martin","year":"2019","unstructured":"Martin B et al (2019) Reduced Tregs in Graves\u2019 orbitopathy. J Immunol Res 45(2):102\u2013109","journal-title":"J Immunol Res"},{"issue":"5","key":"3564_CR33","first-page":"102620","volume":"19","author":"SM McLachlan","year":"2020","unstructured":"McLachlan SM et al (2020) TSHR autoantibodies in GO vs. MG Autoimmun Rev 19(5):102620","journal-title":"MG Autoimmun Rev"},{"issue":"3","key":"3564_CR34","first-page":"920","volume":"102","author":"H Lahooti","year":"2017","unstructured":"Lahooti H et al (2017) Collagen XIII autoantibodies in GO. J Clin Endocrinol Metab 102(3):920\u2013928","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"3564_CR35","volume":"131","author":"CC Krieger","year":"2021","unstructured":"Krieger CC et al (2021) IGF-1R activation in autoimmune disease. J Clin Invest 131(9):e140497","journal-title":"J Clin Invest"},{"issue":"6","key":"3564_CR36","first-page":"2456","volume":"104","author":"RS Douglas","year":"2019","unstructured":"Douglas RS et al (2019) TSHR-IGF-1R crosstalk in GO and RA. J Clin Endocrinol Metab 104(6):2456\u20132465","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3564_CR37","first-page":"282","volume":"89","author":"MJ Simmonds","year":"2018","unstructured":"Simmonds MJ et al (2018) HLA-DR3 and autoimmune thyroid diseases. Clin Endocrinol (Oxf) 89(3):282\u2013290","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"3564_CR38","first-page":"102","volume":"83","author":"X Yin","year":"2022","unstructured":"Yin X et al (2022) CTLA-4 gene polymorphisms in GO and RA. Hum Immunol 83(2):102\u2013110","journal-title":"Hum Immunol"},{"key":"3564_CR39","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1089\/thy.2000.10.1093","volume":"10","author":"DH Khoo","year":"2000","unstructured":"Khoo DH, Eng PH, Ho SC, Tai ES, Morgenthaler NG, Seah LL, Fong KS, Chee SP, Choo CT, Aw SE (2000) Graves\u2019 ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels. Thyroid 10:1093\u20131100","journal-title":"Thyroid"},{"key":"3564_CR40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2265.2000.00959.x","volume":"52","author":"MN Gerding","year":"2000","unstructured":"Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF (2000) Association of thyrotrophin receptor antibodies with the clinical features of Graves\u2019 ophthalmopathy. Clin Endocrinol 52:267\u2013271","journal-title":"Clin Endocrinol"},{"key":"3564_CR41","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","volume":"91","author":"AK Eckstein","year":"2006","unstructured":"Eckstein AK, Plicht M, Lax H, Neuhauser M, Mann K, Lederbogen S, Heckmann C, Esser J, Morgenthaler NG (2006) Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 91:3464\u20133470","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"3564_CR42","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1172\/JCI26031","volume":"115","author":"TF Davies","year":"2005","unstructured":"Davies TF, Ando T, Lin RY, Tomer Y, Latif R (2005) Thyrotropin receptor\u2013associated diseases: from adenomata to Graves disease. J Clin Investig 115(8):1972\u20131983","journal-title":"J Clin Investig"},{"key":"3564_CR43","doi-asserted-by":"crossref","first-page":"13733","DOI":"10.1016\/S0021-9258(17)36705-4","volume":"269","author":"A Allgeier","year":"1994","unstructured":"Allgeier A et al (1994) The human thyrotropin receptor activates G-proteins Gs and Gq\/11. J Biol Chem 269:13733\u201313735","journal-title":"J Biol Chem"},{"key":"3564_CR44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1089\/thy.2007.0239","volume":"17","author":"BR Smith","year":"2007","unstructured":"Smith BR, Sanders J, Furmaniak J (2007) TSH receptor antibodies. Thyroid 17:923\u2013938","journal-title":"Thyroid"},{"key":"3564_CR45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1210\/en.2008-0878","volume":"150","author":"SA Morshed","year":"2009","unstructured":"Morshed SA, Latif R, Davies TF (2009) Characterization of thyrotropin receptor antibodyinduced signaling cascades. Endocrinology 150:519\u2013529","journal-title":"Endocrinology"},{"key":"3564_CR46","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1210\/jc.2014-3566","volume":"100","author":"CC Krieger","year":"2015","unstructured":"Krieger CC, Neumann S, Place RF et al (2015) Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves\u2019 disease immunoglobins. J Clin Endocrinol Metab 100:1071\u20131077","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"3564_CR47","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/jc.2011-0307","volume":"96","author":"WM Wiersinga","year":"2011","unstructured":"Wiersinga WM (2011) Autoimmunity in Graves\u2019 ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors? J Clin Endocrinol Metab 96(8):2386\u20132394","journal-title":"J Clin Endocrinol Metab"},{"key":"3564_CR48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/pr.109.002469","volume":"62","author":"TJ Smith","year":"2010","unstructured":"Smith TJ (2010) Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases? Pharmacol Rev 62:199\u2013236","journal-title":"Pharmacol Rev"},{"key":"3564_CR49","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4049\/jimmunol.168.2.942","volume":"168","author":"J Pritchard","year":"2002","unstructured":"Pritchard J, Horst N, Cruikshank W, Smith TJ (2002) Igs from patients with Graves\u2019 disease induce the expression of T cell chemoattractants in their fibroblasts. J Immunol 168:942\u2013950","journal-title":"J Immunol"},{"key":"3564_CR50","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.4049\/jimmunol.170.12.6348","volume":"170","author":"J Pritchard","year":"2003","unstructured":"Pritchard J, Han R, Horst N, Cruikshank WW, Smith TJ (2003) Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves\u2019 disease is mediated through the IGF-1 receptor pathway. J Immunol 170:6348\u20136354","journal-title":"J Immunol"},{"key":"3564_CR51","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1210\/jc.2012-2270","volume":"98","author":"AJ Varewijck","year":"2013","unstructured":"Varewijck AJ et al (2013) Circulating IgGs may modulate IGF-I receptor stimulating activity in a subset of patients with Graves\u2019 ophthalmopathy. J Clin Endocrinol Metab 98:769\u2013776","journal-title":"J Clin Endocrinol Metab"},{"key":"3564_CR52","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1210\/jc.2012-1771","volume":"98","author":"WB Minich","year":"2013","unstructured":"Minich WB et al (2013) Autoantibodies to the IGF1 receptor in Graves\u2019 orbitopathy. J Clin Endocrinol Metab 98:752\u2013760","journal-title":"J Clin Endocrinol Metab"},{"key":"3564_CR53","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1210\/jc.2013-1004","volume":"98","author":"TJ Smith","year":"2013","unstructured":"Smith TJ (2013) Is IGF-I receptor a target for autoantibody generation in Graves\u2019 disease? J Clin Endocrinol Metab 98:515\u2013518","journal-title":"J Clin Endocrinol Metab"},{"key":"3564_CR54","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.178.5.3281","volume":"178","author":"RS Douglas","year":"2007","unstructured":"Douglas RS, Gianoukakis AG, Kamat S, Smith TJ (2007) Aberrant expression of the insulinlike growth factor-1 receptor by T cells from patients with Graves\u2019 disease may carry functional consequences for disease pathogenesis. J Immunol 178:3281\u20133287","journal-title":"J Immunol"},{"key":"3564_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2018.11.00","author":"CM Longo","year":"2018","unstructured":"Longo CM, Higgins PJ (2018) Molecular biomarkers of Graves\u2019 ophthalmopathy. Exp Mol Pathol. https:\/\/doi.org\/10.1016\/j.yexmp.2018.11.00","journal-title":"Exp Mol Pathol"},{"key":"3564_CR56","first-page":"1268","volume":"83","author":"RA Metcalfe","year":"1998","unstructured":"Metcalfe RA, McIntosh RS, Marelli-Berg F, Lombardi G, Lechler R, Weetman AP (1998) Detection of CD40 on human thyroid follicular cells: analysis of expression and function. J Clin Endocrinol Metab 83:1268\u20131274","journal-title":"J Clin Endocrinol Metab"},{"key":"3564_CR57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-2001-11018","volume":"109","author":"PM Schumm-Draeger","year":"2001","unstructured":"Schumm-Draeger PM (2001) Sodium\/iodide symporter (NIS) and cytokines. Exp Clin Endocrinol Diabetes 109:32\u201334","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"106","key":"3564_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexmp.2018.11.004","volume":"1","author":"CM Longo","year":"2019","unstructured":"Longo CM, Higgins PJ (2019) Molecular biomarkers of Graves\u2019 ophthalmopathy. Exp Mol Pathol 1(106):1\u20136","journal-title":"Exp Mol Pathol"},{"key":"3564_CR59","doi-asserted-by":"crossref","unstructured":"Dwivedi J, Wal P, Dash B, Ovais M, Sachan P, Verma V. (2023) Diabetic pneumopathy-a novel diabetes-associated complication: pathophysiology, the underlying mechanism and combination medication. Endocrine, Metabolic & Immune Disorders Drug Targets.","DOI":"10.2174\/0118715303265960230926113201"},{"issue":"3","key":"3564_CR60","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/jamaophthalmol.2014.5103","volume":"133","author":"JD Stein","year":"2015","unstructured":"Stein JD, Childers D, Gupta S, Talwar N, Nan B, Lee BJ et al (2015) Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves\u2019 disease. JAMA Ophthalmol 133(3):290\u2013296","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"3564_CR61","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/archopht.1993.01090020051022","volume":"111","author":"DL Kendler","year":"1993","unstructured":"Kendler DL, Lippa J, Rootman J (1993) The initial clinical characteristics of Graves\u2019 orbitopathy vary with age and sex. Arch Ophthalmol 111(2):197\u2013201. https:\/\/doi.org\/10.1001\/archopht.1993.01090020051022","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"3564_CR62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2265.1995.tb02597.x","volume":"42","author":"P Perros","year":"1995","unstructured":"Perros P, Crombie AL, Kendall-Taylor P (1995) Natural history of thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) 42(1):45\u201350. https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb02597.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"3564_CR63","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s00417-015-3156-2","volume":"253","author":"GJ Ben Simon","year":"2015","unstructured":"Ben Simon GJ, Katz G, Zloto O et al (2015) Age differences in clinical manifestation and prognosis of thyroid eye disease. Graefes Arch Clin Exp Ophthalmol 253(12):2301\u20132308. https:\/\/doi.org\/10.1007\/s00417-015-3156-2","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3564_CR64","first-page":"73","volume":"4","author":"WR Nunery","year":"1991","unstructured":"Nunery WR (1991) Ophthalmic Graves\u2019 disease: a dual theory of pathogenesis. Ophthalmol Clin N Am 4:73\u201387","journal-title":"Ophthalmol Clin N Am"},{"issue":"7","key":"3564_CR65","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1089\/thy.2010.1634","volume":"20","author":"MN Stan","year":"2010","unstructured":"Stan MN, Bahn RS (2010) Risk factors for development or deterioration of Graves\u2019 ophthalmopathy. Thyroid 20(7):777\u2013783. https:\/\/doi.org\/10.1089\/thy.2010.1634","journal-title":"Thyroid"},{"issue":"3","key":"3564_CR66","first-page":"403","volume":"7","author":"CL Chng","year":"2014","unstructured":"Chng CL, Lai OF, Chew CSM et al (2014) Hypoxia increases adipogenesis and affects adipocytokine production in orbital fibroblasts\u2014a possible explanation of the link between smoking and Graves\u2019 ophthalmopathy. Int J Ophthalmol 7(3):403\u2013407","journal-title":"Int J Ophthalmol"},{"key":"3564_CR67","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1530\/eje.1.01991","volume":"153","author":"GE Krassas","year":"2005","unstructured":"Krassas GE, Segni M, Wiersinga WM (2005) Childhood Graves\u2019 ophthalmopathy: results of a European questionnaire study. Eur J Endocrinol Eur Fed Endocr Soc 153:515\u2013521. https:\/\/doi.org\/10.1530\/eje.1.01991","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"issue":"3","key":"3564_CR68","first-page":"218","volume":"4","author":"GE Krassas","year":"2007","unstructured":"Krassas GE, Perros P (2007) Prevention of thyroid associated ophthalmopathy in children and adults: current views and management of preventable risk factors. Pediatr Endocrinol Rev 4(3):218\u2013224","journal-title":"Pediatr Endocrinol Rev"},{"issue":"6","key":"3564_CR69","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1365-2265.2008.03279","volume":"69","author":"SH Acharya","year":"2008","unstructured":"Acharya SH, Avenell A, Philip S et al (2008) Radioiodine therapy (RAI) for Graves\u2019 disease (GD) and the effect on ophthalmopathy: a systematic review. Clin Endocrinol (Oxf) 69(6):943\u2013950. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03279","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3564_CR70","first-page":"1063","volume":"6","author":"T McCorquodale","year":"2012","unstructured":"McCorquodale T, Lahooti H, Gopinath B, Wall JR (2012) Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy. Clin Ophthalmol 6:1063\u20131071","journal-title":"Clin Ophthalmol"},{"key":"3564_CR71","volume":"99","author":"H Chen","year":"2014","unstructured":"Chen H, Mester T, Raychaudhuri N, Kauh CY, Gupta S, Smith TJ et al (2014) Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes. J Clin Endocrinol Metab 99:E1635-40","journal-title":"J Clin Endocrinol Metab"},{"key":"3564_CR72","doi-asserted-by":"crossref","first-page":"895901","DOI":"10.1155\/2008\/895901","volume":"2008","author":"GM Lehmann","year":"2008","unstructured":"Lehmann GM, Garcia-Bates TM, Smith TJ, Feldon SE, Phipps RP (2008) Regulation of lymphocyte function by PPARgamma: relevance to thyroid eye disease-related inflammation. PPAR Res 2008:895901","journal-title":"PPAR Res"},{"issue":"9","key":"3564_CR73","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.eye.6702603","volume":"21","author":"J Thornton","year":"2007","unstructured":"Thornton J, Kelly SP, Harrison RA, Edwards R (2007) Cigarette smoking and thyroid eye disease: a systematic review. Eye 21(9):1135\u20131145","journal-title":"Eye"},{"key":"3564_CR74","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2265.1992.tb01445.x","volume":"36","author":"M Tellez","year":"1992","unstructured":"Tellez M, Cooper J, Edmonds C (1992) Graves\u2019 ophthalmopathy in relation to cigarette smoking and ethnic origin. Clin Endocrinol 36:291\u2013294","journal-title":"Clin Endocrinol"},{"key":"3564_CR75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2265.1998.00487.x","volume":"49","author":"AP Weetman","year":"1998","unstructured":"Weetman AP, Wiersinga WM (1998) Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey. Clin Endocrinol 49:21\u201328","journal-title":"Clin Endocrinol"},{"issue":"1","key":"3564_CR76","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clinbiochem.2004.09.015","volume":"38","author":"J Bednarek","year":"2005","unstructured":"Bednarek J, Wysocki H, Sowinski J (2005) Oxidative effect of methimazole treatment in patients with and without infiltrative ophthalmolopathy. Clin Biochem 38(1):13\u201318","journal-title":"Clin Biochem"},{"issue":"1","key":"3564_CR77","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EJE-12-0539","volume":"168","author":"G Falgarone","year":"2013","unstructured":"Falgarone G, Heshmati HM, Cohen R, Reach G (2013) Mechanisms in endocrinology. Role of emotional stress in the pathophysiology of Graves\u2019 disease. Eur J Endocrinol 168(1):R13\u2013R18","journal-title":"Eur J Endocrinol"},{"key":"3564_CR78","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fnut.2019.00141","volume":"6","author":"J Alwarith","year":"2019","unstructured":"Alwarith J, Kahleova H, Rembert E et al (2019) Nutrition interventions in rheumatoid arthritis: the potential use of plant-based diets. A review Front Nutr 6:141. https:\/\/doi.org\/10.3389\/fnut.2019.00141","journal-title":"A review Front Nutr"},{"issue":"6S","key":"3564_CR79","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/IOP.0000000000002466","volume":"39","author":"HO Ueland","year":"2023","unstructured":"Ueland HO, Neset MT, Methlie P, Ueland G\u00c5, Pakdel F, R\u00f8dahl E (2023) Molecular biomarkers in thyroid eye disease: a literature review. Ophthalmic Plast Reconstr Surg 39(6S):S19-28","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"15","key":"3564_CR80","doi-asserted-by":"crossref","first-page":"6038","DOI":"10.7150\/ijbs.103977","volume":"20","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zhou Y, Yu B, Deng Y, Wang Y, Fang S, Song X, Fan X, Zhou H (2024) Multi-omics Approaches to discover biomarkers of thyroid eye disease: a systematic review. Int J Biol Sci 20(15):6038","journal-title":"Int J Biol Sci"},{"issue":"18","key":"3564_CR81","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","volume":"376","author":"TJ Smith","year":"2017","unstructured":"Smith TJ, Kahaly GJ, Ezra DG et al (2017) Teprotumumab for thyroid-associated ophthalmopathy. N Engl J Med 376(18):1748\u20131761","journal-title":"N Engl J Med"},{"issue":"4","key":"3564_CR82","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","volume":"382","author":"RS Douglas","year":"2020","unstructured":"Douglas RS, Kahaly GJ, Patel A et al (2020) Teprotumumab efficacy and safety in a Phase 3 study of thyroid eye disease. N Engl J Med 382(4):341\u2013352","journal-title":"N Engl J Med"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03564-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03564-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03564-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:05:24Z","timestamp":1766167524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03564-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3564"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03564-9","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"197"}}